Skip to main content
Log in

Pentoxifylline in arterial disease of the legs

  • Editorial
  • Published:
European Journal of Clinical Pharmacology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

References

  1. Dormandy J, Mahir M, Ascády G, Balsano F, De Leeuw P, Blombery P, Bousser MG, Clement D, Coffman J, Deutschinoff A, Blétry O, Hampton J, Mahler F, Ohlin P, Rieger H, Stranden E, Turpie AGG, Urai L, Verstraete M (1989) Fate of the patient with chronic leg ischemia. A review article. J Cardiovasc Surg 30: 50–57

    Google Scholar 

  2. Duffield RG, Lewis B, Miller NE, Jamieson CW, Brunt JN, Colchester AC (1983) Treatment of hyperlipidaemia retards progression of symptomatic femoral atherosclerosis. Lancet II: 639–642

    Google Scholar 

  3. Quick CGR, Cotton LT (1982) The measured effect of stopping smoking on intermittent claudication. Br J Surg 69 [Suppl]: 24–26

    Google Scholar 

  4. Larsen OA, Larsen NA (1966) Effect of daily muscular exercise in patients with intermittent claudication. Lancet II: 1093–1096

    Google Scholar 

  5. Creasy TS, McMillan PJ, Fletcher EWL, Collin J, Morris PJ (1990) Is percutaneous transluminal angioplasty better than exercise for claudication? Preliminary results from a prospective randomised trial. Eur J Vasc Surg 4: 135–140

    Google Scholar 

  6. Verhaeghe R, Bounameaux H (1991) Peripheral arterial occlusion: thromboembolism, antithrombotic and thrombolytic therapy. In: Fuster V, Verstraete M (eds) Thrombosis in cardiovascular diseases. Saunders, Philadelphia (in press)

    Google Scholar 

  7. Ward A, Clissold SP (1987) Pentoxifylline. A review of its pharmacodynamic and pharmacokinetic properties and its therapeutic efficacy. Drugs 39: 50–97

    Google Scholar 

  8. Porter JM, Cutler BS, Lee BY, Reich T, Reichle FA, Scogin JT, Strandness DE (1982) Pentoxifylline efficacy in the treatment of intermittent claudication: multicenter controlled double-blind trial with objective assessment of chronic occlusive arterial disease patients. Am Heart J 104: 66–72

    Google Scholar 

  9. Gillings D, Koch G, Reich T, Stager WJ (1987) Another look at the pentoxifylline efficacy data for intermittent claudication. J Clin Pharmacol 27: 601–609

    Google Scholar 

  10. Lindgärde F, Jelnes R, Björkman H, Adielsson G, Kjellström T, Palmquist I, Stavenow L (1989) Conservative drug treatment in patients with moderately severe chronic occlusive peripheral arterial disease. Circulation 80: 1549–1556

    Google Scholar 

  11. Cameron HA, Waller PC, Ramsay LE (1988) Drug treatment of intermittent claudication: a critical analysis of the methods and findings of published clinical trials, 1965–1985. Br J Clin Pharmacol 26: 569–576

    Google Scholar 

  12. Coffman JD (1979) Vasodilator drugs in peripheral vascular diseases. N Engl J Med 300: 713–717

    Google Scholar 

  13. Verstraete M (1982) Current therapy for intermittent claudication. Drugs 24: 240–247

    Google Scholar 

  14. Dormandy JA, Hoare E, Colley J, Arrowsmith DE, Dormandy TL (1973) Clinical, haemodynamic, rheological, and biochemical findings in 126 patients with intermittent claudication. Br Med J 4: 576–581

    Google Scholar 

  15. Reid HL, Dormandy JA, Barnes JA, Lock PF, Dormandy TL (1976) Impaired red cell deformability in peripheral vascular disease. Lancet I: 666–668

    Google Scholar 

  16. Angelkort B, Maurin N, Boateng K (1979) Influence of pentoxifylline on erythrocyte deformability in peripheral occlusive arterial disease. Curr Med Res Opin 6: 255–258

    Google Scholar 

  17. Matrai A, Ernst E, Flute PJ, Dormandy JA (1984) Blood filterability in peripheral vascular disease: red cell deformability or cell sticking. Clin Hemorrh 4: 311–325

    Google Scholar 

  18. Bareford D, Lucas GS, Caldwell NM, Stone PCW, Baar S, Stuart J (1985) Erythrocyte deformability in peripheral occlusive arterial disease. J Clin Pathol 38: 135–139

    Google Scholar 

  19. Ehrly AM (1978) The effect of pentoxifylline on the flow properties of human blood. Curr Med Res Opin 5: 608–613

    Google Scholar 

  20. Angelkort B, Spürk P, Habbaba A, Mähder M (1985) Blood flow properties and walking performances in chronic arterial occlusive disease. Angiology 36: 285–292

    Google Scholar 

  21. Schmalzer EA, Chien S (1984) Filterability of subpopulations of leukocytes: effect of pentoxifylline. Blood 64: 542–546

    Google Scholar 

  22. Thao Chan M, Conan F, Roche M, Motta C (1987) Effect of pentoxifylline on the lymphocyte membrane fluidity in peripheral vascular disease patients. In: Mandell GL, Novick WJ (eds) Pentoxifylline and leukocyte function. Hoechst-Roussel Pharmaceuticals Inc, pp 238–244

  23. Clemens MR, Ruess M (1991) The effect of pentoxifylline on erythrocyte membrane and plasma lipids. Eur J Clin Pharmacol 41: 623–624

    Google Scholar 

  24. Ciuffetti G, Mercuri M, Ott C, Lombardini R, Paltriccia R, Lupattelli G, Santambrogio L, Mannarino E (1991) The uses of pentoxifylline as an inhibitor of free radical generation in peripheral vascular disease. Eur J Clin Pharmacol 41: 511–515

    Google Scholar 

  25. Johnson WC, Sentissi JM, Baldwin D, Hamilton J, Dion J (1987) Treatment of claudication with pentoxifylline: are benefits related to improvement in viscosity? J Vasc Surg 6: 211–216

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Verhaeghe, R., Verstraete, M. Pentoxifylline in arterial disease of the legs. Eur J Clin Pharmacol 41, 507–509 (1991). https://doi.org/10.1007/BF00314975

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00314975

Key words

Navigation